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1. ~t~duction 
There is strong evidence, although no definite 
proof, from electrophysiological, morphological or 
biochemical studies [l-4] that glutamate isa neuro- 
transmitter in the mammalian central nervous ystem. 
Granule cells in cerebellum, where they represent by 
far the predominant neuronal cell population, might 
use glutamic acid as neurotransmitter [5--91. Recently 
a high affinity binding site for [3H]glutamate, asso- 
ciated with cerebellar membranes has been described 
[lo]. Here we describe the property of such a binding 
site. In addition we report on its accumulation during 
cerebellar development. In rat cerebellum, granule 
cells originate from the postnatal multiplication of 
the cells of the external germinal layer. Parallel fibers, 
the axons of granule cells, make synapses mainly with 
the dendritic spines of Purkinje cells. Purkinje cells 
are present at birth, but their dendrites are formed 
postnatally simultaneously with granule cell forma- 
tion and maturation. 
2. Experimental 
All the chemicals used were of analytical grade. 
The animafs were inbred Wistar albino rats from our 
laboratory. To avoid discrepancies due to nutritional 
factors, mothers were fed ad libitum and each litter 
was reduced to 6 pups immediately after birth. Rats 
were killed by decapitation, the skull was opened and 
the cerebellum was removed by sectioning its pedun- 
culi as close as possible to the cerebellum. Cerebella 
were :
(i) Rinsed with 0.32 M sucrose in 50 mM Tris-HCl 
buffer (pH 7.1); 
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(ii) Pooled (the number of cerebella in each pool 
depended on the age of the animals as is shown 
in fig.4B); 
(iii) Homogenized (in the same sucrose-containing 
buffer) (1 /I 0, w/v) using a Potter-Elvehjem 
Teflon-glass homogenizer. 
The homogenate was centrifuged at 1000 X g for 10 
min and the pellet (which contains cell nuclei, debris, 
some myelin and glomeruli) was washed once in the 
same sucrose containing buffer. The supernatants 
were pooled, centrifuged (60 min, 100 000 X g) and 
the resulting pellet, which corresponds to pooled 
‘crude mitochondrial’ and ‘microsom~ fractions, 
was stored at - 5O’C. In order to eliminate mainly 
endogenous glutamate but also sucrose and ions, and 
before proceeding to the binding assay, the pellet was 
thawed and osmotically shocked by suspension i
10 mM Tris-HCI buffer (pH 7.1) for 1 h at room 
temperature, then centrifuged (60 min, 100 000 X g) 
and resuspended (l-2 mg protein/ml) in 50 mM 
Tris-HCl buffer (pH 7.1). This suspension isdefined 
as ‘crude membrane fraction’. 
2.1. ~j~d~~g assay pmcedure 
Glutamate binding was deter~ned by adding (in 
triplicate, and in 1.3 mI centrifuge cellulose acetate 
tubes (Du Pont de Nemours)) 200 ,uI of each crude 
membrane fraction (-0.2-0.3 mg protein in the same 
buffer as above) to the incubation medium (final vol. 
1 ml) containing: 
(i) L- [ 3H]Glutamate (5 1 Ci/mmol, New England 
Nuclear) at the same concentration (ml O-’ M or 
5 X 10’ dpmlml); 
(ii) Unlabelled L-glutamate and/or non-radioactive 
presumed ~~bitors of glutamate binding, at dif- 
ferent con~ntrations; 
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(iii) Bovine serum albumin (Sigma) (final cont. 0.1%) 
to reduce adsorption of the radioactive label to 
the surface of the tube. 
A 30 min incubation at 25’C was chosen on the basis 
of the time and temperature curves of glutamate bind- 
ing (fig.2). Incubation was terminated by centrifuga- 
tion at 4°C for 1 h at 15 000 X g. Pre~minary experi- 
ments in which centrifugation time and speed were 
assayed had shown that in the hypotonic medium 
used and after the elimination of most of the sucrose, 
all ghttamate binding membranes sedimented in these 
conditions. The final pellet was super~ci~ly rinsed 
with ice-cold buffer, dissolved in 1 ml NaOH 1 M at 
80°C and counted for 3H. Points were rejected if 
counts differed by >lO%. Protein was measured by 
the method in [I 11. 
Thin layer chromatography (HPTLC precoated 
plates; solvent = methyl acetate 45lisopropanol 
30/water 20) of extracts of the ‘crude membrane 
fraction’ after 30 min incubation shows that no radio- 
activity was detectable outside the glutamate spot 
and thus that L-[‘HIglutamate was not significantly 
metabolised during the incubation (results not 
shown). 
3. Results and discussion 
3.1. Cnrde membrane fraction 
As a first step for the quantitation of glutamate 
binding sites in the cerebellum, we preferred to use 
a membrane fraction which included all neuronal 
membranes rather than a more purified membrane 
fraction prepared from a ‘nerve-ending subcellular 
fraction’ since: 
(i) The yield of a purified nerve ending membrane 
fraction is not quantitative; 
(ii) Post-synaptic membranes do not always remain 
attached to the terminal buttons; 
(iii) Nerve terminals in the developing central nervous 
system change in size and possibly in density 
during development. Moreover cerebellar neuro- 
nal plasma membranes, including those of nerve 
endings, can be prepared by simple osmotic 
shock-centrifugation f the pooled ‘crude mito- 
chondrial’ and ‘microsomal’ fractions. Evidently 
this crude membrane fraction contains also glial 
cells plasma membrane, intracellular membranes, 
mitochondria nd other organelles. Most of these 
membranes should not interfere with glutamate 
binding to neuronal plasma membrane whereas 
mitochondria could. However, in the conditions 
of incubation used glutamate appears not to be 
metabolised. Plasma membranes of the multi- 
synaptic omplexes called glomeruli, of some 
nerve endings, and of some myehnated axons are 
not present in this fraction since they sediment 
in the ‘nuclear fraction’. The nuclear fraction was 
discarded to avoid problems due to the gelifica- 
tion of DNA during incubation. A study on glu- 
tamate binding to the membranes of the nuclear 
fractions, isolated by sucrose gradient centrifu- 
gation, is now in progress. 
3 -2. Properties of glutumate binding 
As shown in fig.1, the binding of L-[3H]ghrtamate 
to the ‘crude membrane fraction’ of adult rat cerebel- 
lum has two components: one is not saturable, and is 
considered as ‘non-specific’ binding; the other, deter- 
mined by the method in [ 121, reaches aplateau at 
-0.6 pM glutamate and is defined as ‘specific bind- 
ing’. Figure 3 shows the analysis (Scatchard plot 
and, in the insert, Hill plot) of ‘specific’ binding in a 
typical experiment. The dissociation constant (fed) of 
specific ‘binding’ was 0.22 + 0.13 PM. This is in good 
agreement with the data in [10,13,14]. However the 
density of sites (10.1 z!z 2.2 pmol/mg protein) is much 
lower than the value found in [lo]. The Hill number 
(nR) was calculated and was statistically not different 
Fig.1. L-[ aH]Glutamate binding: Typical saturation curve 
obtained with a ‘crude membrane fraction’ prepared from 
adult rat cerebella. ‘Specific binding’ was calculated according 
to [4] as follows: non-specific binding (-•-) was extra- 
polated from the slope of the curve of total binding 
(-v-) at high concentration. Specific binding (---A-) 
was obtained by subtracting, at each point, the calculated 
nonspecific binding (-o-) from the total binding measured. 
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Fig.2. Physical properties of L-[‘HIglutamate binding. (A) 
shows the kinetics of binding of L-[ 3H]glutamate for various 
incubation times. The dxperiment was performed at 25*C. 
(B) shows the temperature dependence. Incubation was for 30 
min. 
from unity and thus no positive or negative coopera- 
tivity is present in the conditions of our binding assay. 
Because of our experimental conditions (i.e., centri- 
fugation time) the kinetics of association could not 
be determined. 
‘Specific’ binding occurs in a sodium-free medium, 
it is slightly inhibited by increasing ionic strength of 
the assay medium (results not shown) and when the 
assay was performed at 37”C, the ‘specific’ binding 
slightly decreased (-10%) (fig2B); the optimal pH is 
-7.1 (results not shown). The fact that the & found 
in [10,13,14] iS lower than any & measured for glU- 
tamate transport at high or even extra-high affinity 
and the fact that ‘specific’ binding occurs in sodium- 
free medium and at low ionic strength indicate that 
the sites involved in ‘specific’ binding are different 
from those involved in glutamate transport. 
Several compounds added to the incubation 
medium affect to a different extent the ‘specific bind- 
ing’ of L-[3H]glutamate (table I); D-glutamate is an 
I a .\ 4, A 
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Fig.3. L-[‘HIGlutamate binding to a crude membrane frac- 
tion from 10 day old rats. Scatchard analysis of the data: the 
reciprocal value of the slope gives an estimation of the dis- 
sociation constant (rid = 1.3 X lo-’ M). Hill plot, in the 
insert, shows that there is no cooperativity, nH being statis- 
tically not different from unity (for technical procedure see 
section 2). 
inhibitor but it is much less effective than Lgutamate 
itself, hence ‘specific binding’ exhibits some stereo- 
specificity for the ligand; D- or Laspartate are 
also inhibitors but the concentration eeded (1 O-’ M) 
Table 1 
Inhibition of L-1 3H Iglutamate binding by various 
compounds 
Cont. % Inhibit. 
LClutamic acid 
Kainic acid 
Ibotenic acid 
Glutamate diethyl ester 
Glutamate r-methyl ester 
D-Glutamic acid 
D-Aspartic acid 
L-Aspartic acid 
a-Amino adipic acid 
D,L-hom~ysteic acid 
lO+ M 92 
lo-* M 23 
lo-” M 10 
10-I M 20 
1O-5 M 99 
lo-’ M 26 
lo+ M 51 
10“ M 72 
1o-6 M 45 
lo+ M 50 
GABA lo-& M n.s. 
Muscimol lO+ M n.s. 
Amino-oxyacetic acid lo-’ M 
Concanavalin A 1O-6 Ma :;” 
a On the basic of the monomer molecular weight n.s., non 
significant 
Final L-l; ‘Hjglutamate concentration was 1.15 X lo-’ M in 
the assay medium. Inhibitors were present at the indicated 
concentrations 
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for this inhibition is much higher than that of L- [3H] - 
glutamate (1 O-’ M); this is consistent with a specific 
process. Structurally restricted glutamate analogues 
such as kainic acid or ibotenic acid are weak inhib- 
itors in contrast to glutamate?methyl ester which 
almost completely inhibited the binding of L-[3H]- 
glutamate. This effect of y-methyl-glutamate agrees 
with the physiological evidence of a strong antagonist 
effect of y-methyl-glutamate on the receptor of crus- 
tacean neuromuscular junction [ 191. Glutamate dietyl 
ester is a weak inhibitor of L-[3H]glutamate binding; 
this agrees with the results in [lo] but is in contrast 
with [2-41. Specificity of glutamate binding sites is 
also indicated by the lack of effect on this binding 
of y-amino-butyric acid, muscimol and amino-oxyace- 
tic acid (an inhibitor of glutamic acid decarboxylase). 
The pharmacological properties reported here are in 
agreement with the results obtained with the mam- 
malian central nervous system [10,13,15-181. Also 
in agreement with the results in [ 161, Concanavalin A 
inhibits glutamate binding; this suggests that the bind- 
ing site of glutamate could involve a sugar moiety 
of, possibly, a glycoprotein. 
3.3. Glutamate ‘specific ’ binding during cerebellar 
development 
The Kd and nH calculated in all the experiments at 
each age remain constant during development. This 
indicates that only 1 type of receptor might be present 
throughout cerebellar development. The only changes 
of glutamate binding sites detected during cerebellar 
development are quantitative changes (fig.4). 
At the fourth postnatal day, the amount of ‘specif- 
ic’ binding sites is very low as shown in fig.4A,B. It 
increases dramatically during the second and third 
weeks of postnatal life, reaching a plateau around 
day 20 after birth (figAA). In the cerebellum, the 
amount of protein increases more slowly during onto- 
genesis than that of ‘specific’ glutamate binding sites 
and continues to increase after day 20. This explains 
the peak of ‘site density’ (amount of binding sites/mg 
protein) around postnatal day 20 (fig.4B). 
The developmental curve of accumulation of the 
glutamate binding sites on a per cerebellum basis 
(figAA), has the same shape and a slightly retarded 
chronology as compared to that of postnatal accumu- 
lation of DNA in the cerebellum [20]. DNA accumu- 
lation is mainly due to the formation of granule cells 
which are all formed in the second and third post- 
natal week. The formation of each granule cell is fol- 
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Fig.4. Glutamate binding sites during postnatal development 
of rat cerebellum. Changes of the amount of [‘HIglutamate 
‘specifically’ bound to ‘crude membrane’ fractions prepared 
from cerebella of rats of different ages. For each point the 
pmoles of specifically bound [ ‘HIglutamate were determined 
by Scatchard analysis. The values, for the same experiments, 
are expressed in: (A) on a per cerebellum basis (q average 
values f SD); (B) on a per mg protein basis (a, average 
values). The no. expt (before the X) and the no. pooled 
cerebella (after the X) for each experiment are reported near 
each experimental point. ‘Day 0’ is the day of birth. 
lowed within a few days by its migration, axonal 
growth, and the establishment of synapses between 
the parallel fibers and dendritic spines of Purkinje 
cells and of cerebellar folium interneurones other 
than granule cells [2 l-231. Thus our results indicate 
that the formation of the glutamate binding sites 
described here occurs approximately at the same time 
as the formation of synapses between parallel fibers 
and the dendritic spines of their postsynaptic partner 
cells. Further studies are needed however to verify if 
the glutamate binding sites described here correspond 
to the receptor for glutamate and to localize it. 
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